Back

Galectin-3 and dilated cardiomyopathy: distinct effect of pharmacological and genetic interventions

29 April 2017 (09:06 - 09:12)
Organised by:
Congress Presentation Part of: Rapid Fire 1 - Basic Science Dilated cardiomyopathy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Xiao-Jun Du

Baker Heart and Diabetes Institute, Melbourne (Australia)

13 More presentations in this session

Presentation thumbnail
Epac1-mediated RE/mitochondria interactions promotes mitochondrial Ca2+ overload and cell death during ischemia/reperfusion injury
Miss L. Fazal (Paris, FR)
Abstract
Presentation thumbnail
Intramyocardial delivery of mesenchymal stem cells transfected with minicircle-HIF-1a decreases LV adverse remodelling via release of cardioprotective miRNAs and pro-angiogenic factors
Doctor E. Gara (Budapest, HU)
Abstract
Presentation thumbnail
Prophylactic combined heart failure treatment attenuates the development of doxorubicin induced systolic and diastolic dysfunction in rats
Ms M. Lodi (Debrecen, HU)
Abstract Slides Video
Presentation thumbnail
NPA7, an innovative multivalent designer natriuretic peptide: Co-therapy with Furosemide to mediate renoprotection in experimental ADHF
Doctor L. Meems (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Eosinophils have an essential role in promoting a type 2 innate immune response and cardiac repair following myocardial infarction.

Access the full session

Session thumbnail
Rapid Fire 1 - Basic Science

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 09:06 CET
You may be interested in
thumbnail
Congress Presentation
Galectin 3 : possible tool for early detection of LV diastolic dysfunction in asymptomatic survivors of childhood, adolescent and young adult cancer
20 June 2025
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Presentation
Correlation of the novel biomarker cellular communication network factor 1 (CCN1) with miR-155 in serum of patients with dilated cardiomyopathy
26 August 2023
thumbnail
Congress Presentation
Influence of therapy in patients with CAD and type 2 diabetes on inflamation biomarkers P-selectin and Galectin-3 changes
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources